One-stop gene therapy could wipe out hemophilia, say UCL researchers
Scientists believe they have developed one-stop gene therapy that could almost eradicate haemophilia.
Archives for December 13, 2011
UPDATE
Chairman's departure not due to investor pressure says Hospira
Hospira says Chairman Christopher Begley’s impending retirement is unrelated to quality problems at manufacturing plant or recent investor criticism.
ADC Bio wins development grant for new ADC production tech
ADC Biotechnology (ADC Bio) has secured a development grant for a new antibody drug conjugate (ADC) manufacturing technology that, it says, can make drug production cheaper.
CRL’s preclinical arm will struggle, but RMS and strategic deals hold hope for 2012
Charles River Laboratories’ (CRL) preclinical division will continue to struggle in 2012 but the recent uptick in strategic partnership activity is a ray of hope according to a leading analyst.
Warnex sells medical labs business to Gamma-Dynacare Medical Laboratories
Canadian contract testing firm Warnex has sold its medical lab division to Gamma-Dynacare Medical Laboratories as part of an ongoing strategic review.
Quotient says screening of prototype formulations is crucial to drug delivery
Quotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases.